Skip to Main content Skip to Navigation
Journal articles

Evaluating the Relevance of Virtual Drugs

Abstract : Information about drugs is numerous and varied, and many drugs can share the same information. Grouping drugs that have common characteristics can be useful to avoid redundancy and facilitate interoperability. Our work focused on the evaluation of the relevance of classes allowing this type of grouping: the "Virtual Drug". Thus, in this paper, we describe the process of creating this class from the data of the French Public Drug Database, which is then evaluated against the codes of the Anatomical Therapeutic Chemical classification associated with the drugs. Our evaluation showed that 99.55% of the "Virtual Drug" classes have a good intra-class consistency.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03701033
Contributor : Oskar Admin Connect in order to contact the contributor
Submitted on : Tuesday, June 21, 2022 - 3:48:58 PM
Last modification on : Thursday, June 23, 2022 - 11:50:05 AM

File

BPH_IOSPress_2022_Awuklu.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

Yvon K. Awuklu, Vianney Jouhet, Sebastien Cossin, Frantz Thiessard, Romain Griffier, et al.. Evaluating the Relevance of Virtual Drugs. Studies in Health Technology and Informatics, IOS Press, 2022, Challenges of Trustable AI and Added-Value on Health, 294, pp.322-326. ⟨10.3233/shti220467⟩. ⟨hal-03701033⟩

Share

Metrics

Record views

1

Files downloads

3